T. Stalling et al. · The Synthesis of O,N-Diacyl O,N-Acetals
1051
crude product was crystallized from diethyl ether. The 129.1, 129.6, 137.5 (CAr), 164.5 (CO), 170.0 (CHO) ppm.
title compound was obtained as a colorless solid (1.42 g, – MS (CI, isobutane): m/z (%) = 294.1 (100) [M+H]+. –
5.47 mmol, 55%). M. p. 42 ◦C. – IR (ATR): ν = 2974, 2939, HRMS (CI, isobutane): m/z = 294.1163 (calcd. 294.1164
1727, 1677, 1354, 1218 cm−1. – 1H NMR (500.1 MHz, for C15H20NO3S, [M+H]+).
CDCl3): δ = 1.14 (t, 3J = 7.9 Hz, 3H, CH2CH3), 1.35, 1.53,
(RS)-3-Acetyl-2,2,5,5-tetramethyl-1,3-thiazolidin-4-yl
1.80, 1.91 (4s, 12H, 2 × C(CH3)2), 2.08 (s, 3H, COCH3),
benzoate (2f)
2.46 (q, 3J = 7.9 Hz, 2H, CH2CH3), 6.49 (s, 1H, CH) ppm.
–
13C NMR (125.8 MHz, CDCl3): δ = 9.07 (CH2CH3),
Following the GP, dihydrothiazole 1a (2.86 g,
19.97 mmol), acetyl chloride (1.71 g, 21.79 mmol) and
sodium benzoate (11.52 g, 79.94 mmol) were used. The
crude product was purified by column chromatography on
silica gel (solvent: n-hexane-ethyl acetate, 4 : 1, Rf = 0.48).
The title compound was obtained as a colorless oil (5.34 g,
17.37 mmol, 87%). – IR (ATR): ν = 2986, 2929, 1748,
1344, 1211, 705 cm−1. – 1H NMR (500.1 MHz, CDCl3):
δ = 1.26, 1.59, 1.88, 1.94 (4s, 12H, 2 × C(CH3)2), 2.14 (s,
20.5 (COCH3), 23.1, 29.5, 29.8, 23.8 (2 × C(CH3)2), 26.9
(CH2CH3), 53.2 (C(CH3)2), 68.5 (C(CH3)2), 101.5 (CH),
169.1, 173.4 (2 × CO) ppm. – MS (CI, isobutane): m/z
(%) = 260.2 (100) [M+H]+. – HRMS (CI, isobutane):
m/z = 260.1321 (calcd. 260.1320 for C12H22NO3S,
[M+H]+).
(RS)-2,2,5,5-Tetramethyl-3-[(2E)-3-phenylprop-2-enoyl]-
1,3-thiazolidin-4-yl acetate (2d)
3H, COCH3), 6.64 (s, 1H, CH), 7.38–8.11 (m, 5H, CHAr
)
ppm. – 13C NMR (125.8 MHz, CDCl3): δ = 21.5, 21.3, 22.9,
29.8, 30.7 (5 × CH3), 54.8 (C(CH3)2), 73.6 (C(CH3)2), 91.7
(CH), 123.5, 124.7, 126.9, 128.7, 128.8, 135.8 (CAr), 167.8,
171.7 (2 × CO) ppm. – MS (CI, isobutane): m/z (%) = 308.0
(100) [M+H]+. – HRMS (CI, isobutane): m/z = 308.1315
(calcd. 308.1320 for C16H22NO3S, [M+H]+).
Following the GP, dihydrothiazole 1a (2.86 g,
19.97 mmol), cinnamoyl chloride (3.66 g, 21.97 mmol)
and sodium acetate (6.56 g, 79.97 mmol) were used. The
crude product was purified by column chromatography on
silica gel (solvent: n-hexane-ethyl acetate, 3 : 2, Rf = 0.80).
The title compound was obtained as a colorless solid
(4.20 g, 12.60 mmol, 63%). M. p. 149 ◦C. – IR (ATR):
ν = 2995, 2977, 2932, 1718, 1668, 740 cm−1. – 1H NMR
(500.1 MHz, CDCl3): δ = 1.40, 1.57, 1.88, 2.02 (4s, 12H,
2 × C(CH3)2), 2.09 (s, 3H, COCH3), 6.76 (s, 1H, NCH),
6.96 (d, 3J = 15.4 Hz, 1H, CH=CHPh), 7.30 – 7.50 (m,
5H, CHAr), 7.68 (d, 3J = 15.4 Hz, 1H, CH=CHPh) ppm.
(RS)-2,2-Dimethyl-4-[(2E)-3-phenylprop-2-enoyl]-1-thia-
4-azaspiro[4.5]decan-3-yl acetate (2g)
Following the GP, dihydrothiazole 1b (3.66 g,
19.97 mmol), cinnamoyl chloride (3.66 g, 21.79 mmol)
and sodium acetate (6.56 g, 79.97 mmol) were used. The
crude product was purified by column chromatography on
silica gel (solvent: n-hexane-ethyl acetate, 9 : 1, Rf = 0.37).
The title compound was obtained as a colorless solid
(5.67 g, 15.18 mmol, 76%). M. p. 124 – 125 ◦C. – IR (ATR):
ν = 2991, 2933, 1730, 1658, 1449, 1193, 731 cm−1. – 1H
NMR (500.1 MHz, CDCl3): δ = 1.20 – 1.38, 1.53 – 1.90,
2.82 – 3.25 (3m, 10H, -(CH2)5-), 1.40, 1.52 (2s, 6H,
C(CH3)2), 2.09 (s, 3H, COCH3), 6.78 (s, 1H, NCH), 6.96
(d, 3J = 15.5 Hz, 1H, CH=CHPh), 7.34 – 7.54 (m, 5H,
CHAr), 7.65 (d, 3J = 15.5 Hz, 1H, CH=CHPh) ppm.
–
13C NMR (125.8 MHz, CDCl3): δ = 20.4 (COCH3),
23.9, 29.8, 29.9, 30.7 (2 × C(CH3)2), 51.8 (C(CH3)2), 73.9
(C(CH3)2), 91.4 (NCH), 118.7 (CH=CHPh), 127.9, 128.0,
128.7, 128.8, 129.7, 135.0 (CAr), 144.3 (CH=CHPh), 165.5,
170.4 (2 × CO) ppm. – MS (CI, isobutane): m/z (%) = 334.2
(100) [M+H]+. – HRMS (CI, isobutane): m/z = 334.1476
(calcd. 334.1477 for C18H24NO3S, [M+H]+).
(RS)-3-Benzoyl-2,2,5,5-tetramethyl-1,3-thiazolidin-4-yl
formate (2e)
–
13C NMR (125.8 MHz, CDCl3): δ = 20.4 (COCH3),
Following the GP, dihydrothiazole 1a (1.43 g,
9.98 mmol), benzoyl chloride (1.55 g, 11.03 mmol)
and sodium formate (2.72 g, 40.00 mmol) were used. The
crude product was purified by column chromatography on
silica gel (solvent: n-hexane-ethyl acetate, 1 : 1, Rf = 0.86).
The title compound was obtained as a colorless solid
(1.25 g, 4.26 mmol, 43%). M. p. 113 – 116 ◦C. – IR (ATR):
ν = 2976, 2931, 1718, 1661, 1444, 1068, 698 cm−1. – 1H
NMR (500.1 MHz, CDCl3): δ = 1.20, 1.65, 2.05, 2.10 (4s,
12H, 2 × C(CH3)2), 6.45 (s, 1H, CH), 7.19–8.01 (m, 5H,
CHAr), 7.91 (s, 1H, CHO) ppm. – 13C NMR (125.8 MHz,
CDCl3): δ = 23.2, 30.9, 31.1, 31.6 (2 × C(CH3)2), 52.7
24.1, 24.4 (C(CH3)2), 25.1, 25.3, 25.4, 25.8, 30.0 (-
(CH2)5-), 51.0 (C(CH3)2), 80.2 (C-(CH2)5-), 92.2 (NCH),
119.5 (CH=CHPh), 127.9, 128.0, 128.7, 128.8, 129.7,
135.0 (CAr), 142.8 (CH=CHPh), 165.8, 170.5 (2 × CO)
ppm. – MS (ESI): m/z (%) = 395.9 (100) [M+Na]+.
– HRMS (ESI): m/z = 395.9245 (calcd. 395.9245 for
C21H27NNaO3S, [M+Na]+).
(4R∗,5R∗)-3-Benzoyl-2,2,5-trimethyl-5-phenyl-
1,3-thiazolidin-4-yl acetate (3a)
Following the GP, dihydrothiazole 1c (2.05 g,
(C(CH3)2), 73.0 (C(CH3)2), 94.1 (CH), 125.6, 128.5, 128.6, 9.98 mmol), benzoyl chloride (1.55 g, 10.76 mmol)
Brought to you by | University of California
Authenticated
Download Date | 1/19/16 2:42 PM